Logo image of LASE

LASER PHOTONICS CORP (LASE) Stock Fundamental Analysis

NASDAQ:LASE - Nasdaq - US51807Q1004 - Common Stock - Currency: USD

2.96  -0.04 (-1.33%)

After market: 2.91 -0.05 (-1.69%)

Fundamental Rating

3

Taking everything into account, LASE scores 3 out of 10 in our fundamental rating. LASE was compared to 128 industry peers in the Machinery industry. While LASE has a great health rating, there are worries on its profitability. LASE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

LASE had negative earnings in the past year.
In the past year LASE has reported a negative cash flow from operations.
LASE Yearly Net Income VS EBIT VS OCF VS FCFLASE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -2M -4M

1.2 Ratios

LASE's Return On Assets of -103.45% is on the low side compared to the rest of the industry. LASE is outperformed by 93.75% of its industry peers.
Looking at the Return On Equity, with a value of -113.41%, LASE is doing worse than 86.72% of the companies in the same industry.
Industry RankSector Rank
ROA -103.45%
ROE -113.41%
ROIC N/A
ROA(3y)-7.15%
ROA(5y)N/A
ROE(3y)-7.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LASE Yearly ROA, ROE, ROICLASE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 10 -10 -20

1.3 Margins

LASE has a better Gross Margin (45.56%) than 85.16% of its industry peers.
In the last couple of years the Gross Margin of LASE has grown nicely.
The Profit Margin and Operating Margin are not available for LASE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.56%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.39%
GM growth 5YN/A
LASE Yearly Profit, Operating, Gross MarginsLASE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 50 -50

8

2. Health

2.1 Basic Checks

LASE does not have a ROIC to compare to the WACC, probably because it is not profitable.
LASE has more shares outstanding than it did 1 year ago.
There is no outstanding debt for LASE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LASE Yearly Shares OutstandingLASE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2M 4M 6M 8M
LASE Yearly Total Debt VS Total AssetsLASE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

An Altman-Z score of 24.87 indicates that LASE is not in any danger for bankruptcy at the moment.
The Altman-Z score of LASE (24.87) is better than 99.22% of its industry peers.
There is no outstanding debt for LASE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 24.87
ROIC/WACCN/A
WACC9.92%
LASE Yearly LT Debt VS Equity VS FCFLASE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 5.38 indicates that LASE has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 5.38, LASE belongs to the top of the industry, outperforming 93.75% of the companies in the same industry.
LASE has a Quick Ratio of 3.31. This indicates that LASE is financially healthy and has no problem in meeting its short term obligations.
LASE has a Quick ratio of 3.31. This is amongst the best in the industry. LASE outperforms 89.84% of its industry peers.
Industry RankSector Rank
Current Ratio 5.38
Quick Ratio 3.31
LASE Yearly Current Assets VS Current LiabilitesLASE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 5M 10M 15M

2

3. Growth

3.1 Past

LASE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -88.48%.
LASE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -44.08%.
Measured over the past years, LASE shows a very strong growth in Revenue. The Revenue has been growing by 22.37% on average per year.
EPS 1Y (TTM)-88.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.39%
Revenue 1Y (TTM)-44.08%
Revenue growth 3Y22.37%
Revenue growth 5YN/A
Sales Q2Q%-42.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LASE Yearly Revenue VS EstimatesLASE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 1M 2M 3M 4M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LASE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LASE Price Earnings VS Forward Price EarningsLASE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LASE Per share dataLASE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for LASE!.
Industry RankSector Rank
Dividend Yield N/A

LASER PHOTONICS CORP

NASDAQ:LASE (4/30/2025, 8:18:11 PM)

After market: 2.91 -0.05 (-1.69%)

2.96

-0.04 (-1.33%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-11 2023-05-11/bmo
Earnings (Next)N/A N/A
Inst Owners3.18%
Inst Owner Change9.94%
Ins Owners2.85%
Ins Owner Change0%
Market Cap40.94M
AnalystsN/A
Price TargetN/A
Short Float %10.7%
Short Ratio3.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 15.88
P/FCF N/A
P/OCF N/A
P/B 4.23
P/tB 7.23
EV/EBITDA N/A
EPS(TTM)-1.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)-0.61
OCFYN/A
SpS0.19
BVpS0.7
TBVpS0.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -103.45%
ROE -113.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.56%
FCFM N/A
ROA(3y)-7.15%
ROA(5y)N/A
ROE(3y)-7.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.39%
GM growth 5YN/A
F-Score2
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 52.26%
Cap/Sales 17.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.38
Quick Ratio 3.31
Altman-Z 24.87
F-Score2
WACC9.92%
ROIC/WACCN/A
Cap/Depr(3y)54.8%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.27%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-88.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.39%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-44.08%
Revenue growth 3Y22.37%
Revenue growth 5YN/A
Sales Q2Q%-42.18%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1058.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-827.65%
OCF growth 3YN/A
OCF growth 5YN/A